Medication info
Clopidogrel 75 mg (Clopidogrel Bisulfate)

Clopidogrel 75 mg (Clopidogrel Bisulfate)

Prescription medicationTabletOral
Ingredient · strength
Clopidogrel Bisulfate›97.875mg / 1 tablet
Manufacturer / importer
Huons Co., Ltd.
Appearance
Pink round film-coated tablets
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 201207517 · Approved 2012.10.30 · Insurance code 670606340

Summary

Main use
Relief of symptoms of acute coronary syndrome and atherosclerosis, and reduction of the risk of thromboembolism in atrial fibrillation
Who takes it
Adults
Adult dose
○ Adults 1. For patients with ischemic stroke, myocardial infarction, or peripheral arterial disease, administer clopidogrel 75 mg orally once daily. 2. For patients with acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), initiate treatment on the first day with a loading dose of 300 mg once daily, followed by an oral maintenance dose of 75 mg once daily. Aspirin 75 ~ 325 mg should be coadministered with this drug once daily. 3. For patients with atrial fibrillation, administer this drug 75 mg orally once daily. Aspirin 75 ~ 100 mg should be coadministered with this drug once daily. ○ Patients with renal impairment : Treatment experience in patients with renal impairment is limited. ○ Patients with hepatic impairment : Treatment experience in patients with moderate liver disease and a bleeding diathesis is limited. This drug may be administered without regard to food.

Ingredients

Manufacturer
Huons Co., Ltd.

Efficacy & effects

Relief of symptoms of acute coronary syndrome and atherosclerosis, and reduction of the risk of thromboembolism in atrial fibrillation

  • Ischemic stroke
  • myocardial infarction
  • peripheral artery disease
  • acute coronary syndrome
  • unstable angina
  • non-ST elevation myocardial infarction
  • cardiovascular events
  • stroke
  • refractory ischemia
  • vascular risk factors
  • atrial fibrillation
View approved original text

This medication is used to improve symptoms of atherosclerosis in adult patients with ischemic stroke, myocardial infarction, and peripheral artery disease. It also reduces the risk of death, myocardial infarction, and stroke due to cardiovascular events in patients with acute coronary syndrome who have undergone medical therapy, coronary intervention, or coronary artery bypass surgery. Furthermore, it has been shown to lower the risk of stroke and thromboembolism in adult patients with atrial fibrillation who have vascular risk factors but are unable to take vitamin K antagonists. Therefore, this drug is used to improve various thrombotic and atherosclerotic symptoms related to cardiovascular diseases.

How to take

Adult dose

○ Adults 1. For patients with ischemic stroke, myocardial infarction, or peripheral arterial disease, administer clopidogrel 75 mg orally once daily. 2. For patients with acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), initiate treatment on the first day with a loading dose of 300 mg once daily, followed by an oral maintenance dose of 75 mg once daily. Aspirin 75 ~ 325 mg should be coadministered with this drug once daily. 3. For patients with atrial fibrillation, administer this drug 75 mg orally once daily. Aspirin 75 ~ 100 mg should be coadministered with this drug once daily. ○ Patients with renal impairment : Treatment experience in patients with renal impairment is limited. ○ Patients with hepatic impairment : Treatment experience in patients with moderate liver disease and a bleeding diathesis is limited. This drug may be administered without regard to food.

Precautions

This medication helps prevent platelets from aggregating, allowing blood to flow more easily. Certain genetic factors may cause the drug to not work effectively in patients taking this medication, and genetic testing may need to be considered for alternative treatment options. Additionally, taking this medication with certain drugs that activate specific enzymes may increase the risk of bleeding, so combination with such medications is not recommended. This drug should not be administered to patients with a history of hypersensitivity or bleeding, severe liver impairment, breastfeeding women, and certain genetic lactose intolerance patients. Patients with a high risk of bleeding or those scheduled for surgery should exercise caution when using this medication and may need to discontinue the medication 5-7 days prior to surgery if necessary. This medication may increase the risk of bleeding when used in combination with other bleeding risk medications, necessitating careful monitoring during concurrent use. If any bleeding symptoms occur while taking this medication, notify your healthcare provider immediately and have your condition checked through blood tests, etc. Rarely, this medication may cause a serious blood disorder called Thrombotic Thrombocytopenic Purpura (TTP), requiring immediate treatment if related symptoms appear. Possible side effects include bleeding, gastrointestinal symptoms, headache, dizziness, skin rash, etc. Immediate medical attention is necessary for any serious adverse reactions. Use during pregnancy should be carefully considered for potential effects on the fetus, while breastfeeding mothers should determine whether to discontinue breastfeeding, given the possibility of the drug being excreted into breast milk. Elderly patients or those with decreased renal and liver function may have an increased risk of bleeding, thus requiring dosage adjustments and monitoring. In the event of overdose, bleeding time may be prolonged, and due to the lack of a specific antidote, platelet transfusion may be necessary to halt bleeding. Keep this medication out of reach of children, and avoid transferring it to other containers.

Side effects

Hemorrhage, gastrointestinal bleeding, hospitalization required for bleeding, purpura, contusion, hematoma, epistaxis, hematoma, hematuria, intraocular hemorrhage, intracranial hemorrhage, major bleeding, life-threatening bleeding, fatal bleeding, hemorrhagic stroke, need for hemostatic agents, need for blood transfusion, significant functional impairment, intraocular hemorrhage accompanied by significant vision loss, mild bleeding, neutropenia, agranulocytosis, aplastic anemia, thrombocytopenia, abdominal pain, dyspepsia, diarrhea, nausea, rash, pruritus, depression, upper respiratory tract infection, shortness of breath, rhinitis, bronchitis, cough, urinary tract infection, chest pain, accidental injury, influenza-like illness, pain, fatigue, edema, hypertension, headache, dizziness, hypercholesterolemia, arthralgia, low back pain, depression, pneumonia, sinusitis, eczema, skin ulcer, gynecomastia, fever, hypochromic anemia, anemia, thrombocytopenia, bloody stool, thrombocytopenia, thrombocytopenia, vasculitis, hypotension, bronchospasm, interstitial pneumonia, eosinophilic pneumonia, colitis, pancreatitis, gastritis, stomatitis, hepatitis, acute hepatic failure, papular urticaria, erythematous skin rash, urticaria, itching, angioedema, vesicular dermatitis, drug-induced hypersensitivity syndrome, eosinophilia, arthritis, myalgia, glomerular disease, gynecomastia, weight loss, weight gain, facial flushing, weakness, rigidity, facial edema, syncope, cough, shortness of breath, rhinitis, visual disturbances, visual field defects, dry eye syndrome, transient blindness, congestion, tinnitus, taste disturbances, loss of taste, hemothorax, herpes zoster, erythematous rash, papular urticaria, urticaria, renal dysfunction, acute renal failure, cholecystitis, hematemesis, spinal hematoma

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. It is recommended to maintain storage temperatures between 1 to 30 degrees Celsius (room temperature). This way, the effectiveness of the medication can be preserved safely for a long time.

Appearance and packaging

Appearance

Pink round film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.